Hope for rare cancers: Two-Drug combo trial seeks to control tough tumors
Disease control
Ongoing
This study is testing whether a combination of two immunotherapy drugs (ipilimumab and nivolumab) can help control advanced rare cancers that have shown some sensitivity to these treatments before. It will involve 240 adults with specific rare cancers, including certain neuroendo…
Phase: PHASE2 • Sponsor: Olivia Newton-John Cancer Research Institute • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC